Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.

Previous research has suggested an association between antidepressants use and clinical restless legs syndrome (RLS) in patients, but there has never been a single study investigating the risk of RLS in irritable bowel syndrome (IBS) patients treated with antidepressants. Hence, we aimed to explore...

Full description

Bibliographic Details
Main Authors: Yung-Chu Hsu, Hsin-Yi Yang, Wan-Ting Huang, Solomon Chih-Cheng Chen, Herng-Sheng Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0220641
_version_ 1818919173557846016
author Yung-Chu Hsu
Hsin-Yi Yang
Wan-Ting Huang
Solomon Chih-Cheng Chen
Herng-Sheng Lee
author_facet Yung-Chu Hsu
Hsin-Yi Yang
Wan-Ting Huang
Solomon Chih-Cheng Chen
Herng-Sheng Lee
author_sort Yung-Chu Hsu
collection DOAJ
description Previous research has suggested an association between antidepressants use and clinical restless legs syndrome (RLS) in patients, but there has never been a single study investigating the risk of RLS in irritable bowel syndrome (IBS) patients treated with antidepressants. Hence, we aimed to explore the association between IBS and RLS and to examine the risk of RLS in IBS patients treated with antidepressants. With the use of the National Health Insurance Research Database of Taiwan, 27,437 adults aged ≥ 20 years with newly diagnosed IBS (ICD-9-CM Code 564.1) and gender- and age-matched 54,874 controls without IBS were enrolled between 2000 and 2012. All patients were followed-up until RLS diagnosis, withdrawal from the National Health Insurance program, or end of 2013. We used the Cox proportional hazards model to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) of RLS. RLS was more prevalent in IBS patients than in the non-IBS group (7.57 versus 3.36 per 10,000 person-years), with an increased risk of RLS (adjusted HR [aHR], 1.91; 95% CI, 1.52-2.40). Multivariate Cox proportional hazards analysis identified older age (age, 51-65 years; aHR, 1.67; 95% CI, 1.09-2.56; and age > 65; aHR, 1.59; 95% CI, 1.02-2.48), hypothyroidism (aHR, 4.24; 95% CI, 1.92-9.37), CAD (aHR, 1.70; 95% CI, 1.17-2.48), and depression (aHR, 3.15; 95% CI, 2.14-4.64) as independent RLS risk factors in IBS patients. In addition, the male SSRIs users were associated with significantly higher risk of RLS (aHR, 3.05 95% CI, 1.34-6.92). Our study showed that the IBS group has higher risk of RLS. Moreover, SSRIs use may increase the risk of RLS in male IBS patients.
first_indexed 2024-12-20T01:01:39Z
format Article
id doaj.art-7cc0b823467f45aea5035248c0e2603a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T01:01:39Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7cc0b823467f45aea5035248c0e2603a2022-12-21T19:58:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01148e022064110.1371/journal.pone.0220641Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.Yung-Chu HsuHsin-Yi YangWan-Ting HuangSolomon Chih-Cheng ChenHerng-Sheng LeePrevious research has suggested an association between antidepressants use and clinical restless legs syndrome (RLS) in patients, but there has never been a single study investigating the risk of RLS in irritable bowel syndrome (IBS) patients treated with antidepressants. Hence, we aimed to explore the association between IBS and RLS and to examine the risk of RLS in IBS patients treated with antidepressants. With the use of the National Health Insurance Research Database of Taiwan, 27,437 adults aged ≥ 20 years with newly diagnosed IBS (ICD-9-CM Code 564.1) and gender- and age-matched 54,874 controls without IBS were enrolled between 2000 and 2012. All patients were followed-up until RLS diagnosis, withdrawal from the National Health Insurance program, or end of 2013. We used the Cox proportional hazards model to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) of RLS. RLS was more prevalent in IBS patients than in the non-IBS group (7.57 versus 3.36 per 10,000 person-years), with an increased risk of RLS (adjusted HR [aHR], 1.91; 95% CI, 1.52-2.40). Multivariate Cox proportional hazards analysis identified older age (age, 51-65 years; aHR, 1.67; 95% CI, 1.09-2.56; and age > 65; aHR, 1.59; 95% CI, 1.02-2.48), hypothyroidism (aHR, 4.24; 95% CI, 1.92-9.37), CAD (aHR, 1.70; 95% CI, 1.17-2.48), and depression (aHR, 3.15; 95% CI, 2.14-4.64) as independent RLS risk factors in IBS patients. In addition, the male SSRIs users were associated with significantly higher risk of RLS (aHR, 3.05 95% CI, 1.34-6.92). Our study showed that the IBS group has higher risk of RLS. Moreover, SSRIs use may increase the risk of RLS in male IBS patients.https://doi.org/10.1371/journal.pone.0220641
spellingShingle Yung-Chu Hsu
Hsin-Yi Yang
Wan-Ting Huang
Solomon Chih-Cheng Chen
Herng-Sheng Lee
Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.
PLoS ONE
title Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.
title_full Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.
title_fullStr Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.
title_full_unstemmed Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.
title_short Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.
title_sort use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome a population based cohort study
url https://doi.org/10.1371/journal.pone.0220641
work_keys_str_mv AT yungchuhsu useofantidepressantsandrisksofrestlesslegssyndromeinpatientswithirritablebowelsyndromeapopulationbasedcohortstudy
AT hsinyiyang useofantidepressantsandrisksofrestlesslegssyndromeinpatientswithirritablebowelsyndromeapopulationbasedcohortstudy
AT wantinghuang useofantidepressantsandrisksofrestlesslegssyndromeinpatientswithirritablebowelsyndromeapopulationbasedcohortstudy
AT solomonchihchengchen useofantidepressantsandrisksofrestlesslegssyndromeinpatientswithirritablebowelsyndromeapopulationbasedcohortstudy
AT herngshenglee useofantidepressantsandrisksofrestlesslegssyndromeinpatientswithirritablebowelsyndromeapopulationbasedcohortstudy